Aplastic Anemia Trials


Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL) This study is currently recruiting participants. Verified Jun…

Continue reading about Clinical Trial Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia

Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia The recruitment status of this study is unknown because the information has not been verified recently. Verified October 20…

Continue reading about Clinical Trial Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia

Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders

Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders This study has been completed. Fi…

Continue reading about Clinical Trial Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders

A Prospective, Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia (Aplastic Anemia) Mediated by Erythropoietin Antibodies Among Patients With Chronic Kidney Failure and Subcutaneous Exposure to Recombinant Erythropoietin Products

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure (PRIMS) This study has been completed. First Received…

Continue reading about Clinical Trial A Prospective, Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia (Aplastic Anemia) Mediated by Erythropoietin Antibodies Among Patients With Chronic Kidney Failure and Subcutaneous Exposure to Recombinant Erythropoietin Products

Progression of Hematopoietic Diseases in Shanghai, China

Progression of Hematopoietic Diseases in Shanghai, China The recruitment status of this study is unknown because the information has not been verified recently. Verified May 2007 by Universi…

Continue reading about Clinical Trial Progression of Hematopoietic Diseases in Shanghai, China

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide This study is currently recruiting participants. Verified July 2012 by M.D. Anderson Cancer Center …

Continue reading about Clinical Trial Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment This study is currently recruiting participants. Verified April…

Continue reading about Clinical Trial Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment

Collecting and Storing Blood Samples From Patients With Cancer

Collecting and Storing Blood Samples From Patients With Cancer This study has been withdrawn prior to enrollment. ( Will be replaced by honest broker program ) Firs…

Continue reading about Clinical Trial Collecting and Storing Blood Samples From Patients With Cancer

New York Blood Center National Cord Blood Program

New York Blood Center National Cord Blood Program The recruitment status of this study is unknown because the information has not been verified recently. Verified September 2005 by New York …

Continue reading about Clinical Trial New York Blood Center National Cord Blood Program

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome This study is currently recruiting participants. …

Continue reading about Clinical Trial Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome